当前位置: 首页 > 期刊 > 《中国现代医生》 > 20209
编号:13493784
阿托伐他汀对慢性硬膜下血肿患者钻孔术后的影响(4)
http://www.100md.com 2020年3月25日 《中国现代医生》 20209
     [18] Wang D,Li T,Wei H,et al. Atorvastatin enhances angiogenesis to reduce subdural hematoma in a rat model[J]. J Neurol Sci,2016,362:91-99.

    [19] Hong HJ,Kim YJ,Yi HJ,et al. Role of angiogenic growth factors and inflammatory cytokine on recurrence of chronic subdural hematoma[J]. Surg Neurol,2009,71(2):161-166.

    [20] 王坤,李冰,趙鹏,等. 慢性硬膜下血肿患者的临床预后和复发率分析[J]. 中华神经创伤外科电子杂志,2018, 4(5):272-275.

    [21] Rodriguez-Perea AL,Gutierrez-Vargas J,Cardona-Gomez GP,et al. Atorvastatin modulates regulatory T cells and attenuates cerebral damage in a model of transient middle cerebral artery occlusion in rats[J]. J Neuroimmune Pharmacol,2017,12(1):152-162.

    [22] Chen J,Zacharek A,Li A,et al. Atorvastatin promotes presenilin-1 expression and Notch1 activity and increases neural progenitor cell proliferation after stroke[J]. Stroke,2008,39(1):220-226.

    [23] Ducruet AF,Grobelny BT,Zacharia BE,et al. The surgical management of chronic subdural hematoma[J]. Neurosurgical Review,2012,35(2):155-169.

    (收稿日期:2019-12-27), 百拇医药(陈平 王兵 廖泉 梁日初)
上一页1 2 3 4